Sector News

Evonik acquires French biotech company Alkion BioPharma

April 13, 2016
Chemical Value Chain

Evonik has concluded a purchase agreement to take over French start-up Alkion BioPharma. Terms of the deal were not disclosed, but the purchase is expected to complete this month.

Alkion’s strength lies in sustainably developed plant-based ingredients for cosmetics and the acquisition will extend Evonik’s personal care portfolio in the specialty actives field, while Alkion is set to benefit from Evonik’s marketing heft, raising awareness of its specialized extraction technology.

“Thanks to its formulation and application expertise, Evonik enjoys an excellent reputation in the cosmetics industry. We are resolutely continuing along this path with the acquisition of Alkion,” said Dr. Tammo Boinowitz, Head of the Personal Care Business Line at Evonik. “This allows us to offer customers product concepts to set themselves apart from competitors.”

By Georgina Caldwell

Source: Global Cosmetic News

Related News

February 28, 2021

Borealis to invest in new RTO to reduce CO2 emissions at Porvoo polyolefins plant

Chemical Value Chain

This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.

February 28, 2021

Grace to acquire Albemarle’s fine chemistry business for $570 million

Chemical Value Chain

The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.

February 28, 2021

Solvay to carve out soda ash business

Chemical Value Chain

Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.

Send this to a friend